Market Access News | pharmaphorum

News

The UK's system of disclosing payments from pharma to healthcare professionals has gaps that hide potential conflicts of interest, claims study.

News

Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.

News

More community hubs and changes to the NHS App are at the core of the UK government's new elective reform plan.

News

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

News

Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on pharma funding.

News

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.